Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- HC Wainwright & Co. analyst Mitchell S. Kapoor initiated coverage on Crescent Biopharma, Inc. (NASDAQ:CBIO) with a Buy rating and announced a price target of $25. Crescent Biopharma shares closed at $12.85 on Friday. See how other analysts view this stock.
- Oppenheimer analyst …
Full story available on Benzinga.com
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- HC Wainwright & Co. analyst Mitchell S. Kapoor initiated coverage on Crescent Biopharma, Inc. (NASDAQ:CBIO) with a Buy rating and announced a price target of $25. Crescent Biopharma shares closed at $12.85 on Friday. See how other analysts view this stock.
- Oppenheimer analyst …
Full story available on Benzinga.com
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
HC Wainwright & Co. analyst Mitchell S. Kapoor initiated coverage on Crescent Biopharma, Inc. (NASDAQ:CBIO) with a Buy rating and announced a price target of $25. Crescent Biopharma shares closed at $12.85 on Friday. See how other analysts view this stock.
Oppenheimer analyst …Full story available on Benzinga.com Read MoreALM, ARM, CBIO, INVA, News, Top Initiations, Initiation, Pre-Market Outlook, Markets, Analyst Ratings, Trading Ideas, ALM, ARM, INVA, CBIO, News, Initiation, Pre-Market Outlook, Markets, Analyst Ratings, Trading Ideas, Benzinga Markets
